Nalbuphine Hydrochloride
- Product NDC
- 84549-464
- Requested package NDC
- 84549-464-01
- 11-digit product format
- 845490464
- Labeler code
- 84549
- Product ID
- 84549-464_463cff7e-0486-7c6d-e063-6294a90ae0e7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NALBUPHINE HYDROCHLORIDE
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
- Labeler
- ProPharma Distribution
- Application
- ANDA070915
- Marketing category
- ANDA
- Marketing start
- 2005-07-19
- Substance
- NALBUPHINE HYDROCHLORIDE
- Active strength
- 10 mg/mL
- Pharmacologic classes
- Competitive Opioid Antagonists [MoA], Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A070915-001 | NALBUPHINE HYDROCHLORIDE | NALBUPHINE HYDROCHLORIDE | 100MG/10ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RS | 1989-02-03 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A070915-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 100MG/10ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RS | 1989-02-03 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 100MG/10ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RS | 1989-02-03 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 100MG/10ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RS | 1989-02-03 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 100MG/10ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RS | 1989-02-03 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 100MG/10ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RS | 1989-02-03 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A070915-001 | NALBUPHINE HYDROCHLORIDE | 10MG/ML | INJECTABLE / INJECTION | AP | RS | 1989-02-03 | f41ea6bd6efb… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A070915-001 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A070915-001 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A070915-001 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A070915-001 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A070915-001 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A070915-001 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A070915-001 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A070915-001 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A070915-001 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A070915-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A070915-001 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A070915-001 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A070915-001 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A070915-001 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A070915-001 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A070915-001 | AP | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A070915-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A070915-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A070915-001 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A070915-001 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A070915-001 | AP | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A070915-001 | AP | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A070915-001 | AP | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A070915-001 | AP | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A070915-001 | AP | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A070915-001 | AP | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A070915-001 | AP | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A070915-001 | AP | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A070915-001 | AP | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A070915-001 | AP | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A070915-001 | AP | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A070915-001 | AP | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A070915-001 | AP | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A070915-001 | AP | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A070915-001 | AP | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A070915-001 | AP | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A070915-001 | AP | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A070915-001 | AP | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A070915-001 | AP | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A070915-001 | AP | 1 | f41ea6bd6efb… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Nalbuphine Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| NALBUPHINE HYDROCHLORIDE | 10 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| ZU4275277R | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 904415 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 38569b5f-fb37-135e-e063-6294a90a54df | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e665fab2-f6df-99b6-a22d-5d9276f14b80 | Product name | 3 | 20250331 |
| e2db08c6-133f-4f4f-afb4-e90a2418d6f6 | Product name | 1 | 20230320 |
| ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906 | Product name | 7 | 20210625 |
| f52be47f-7aa7-46c0-b1fa-50c18dd50206 | Product name | 1 | 20201029 |
| 11ed6f83-cdd2-4637-8379-b1a1d3ae3cde | Product name | 1 | 20181101 |
| 86c45a79-b9f0-4476-a27c-6e10db098497 | Product name | 1 | 20180125 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 84549-464-01 | Nalbuphine Hydrochloride | 10 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 10 | 4 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nalbuphine Hydrochloride | NALBUPHINE HYDROCHLORIDE | Hospira, Inc. | 6025e8d4-5083-4c3a-58a0-050e7b0b6150 | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | 070915 ANDA070915 |
| Nalbuphine Hydrochloride | NALBUPHINE HYDROCHLORIDE | ProPharma Distribution | 38569b5f-fb37-135e-e063-6294a90a54df | 2025-12-18 | Boxed warning, Warnings, Adverse reactions | 070915 ANDA070915 84549-464-01 84549-464 84549046401 |
| NALBUPHINE HCI | NALBUPHINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 96139914-0708-7b58-e053-2995a90a7308 | 2025-01-08 | Boxed warning, Warnings, Adverse reactions | 070915 ANDA070915 |
| Nalbuphine Hydrochloride | NALBUPHINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 6bde2184-5643-3ec6-e053-2991aa0a115f | 2023-05-23 | Boxed warning, Warnings, Adverse reactions | 070915 ANDA070915 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 904415 | nalbuphine HCl 10 MG/ML Injectable Solution | PSN | 38569b5f-fb37-135e-e063-6294a90a54df | 4 |
| 904415 | nalbuphine hydrochloride 10 MG/ML Injectable Solution | SCD | 38569b5f-fb37-135e-e063-6294a90a54df | 4 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 84549-464-01 | 84549046401 | 10 mL in 1 VIAL, MULTI-DOSE (84549-464-01) | 10 ml | 2025-08-27 | No | No | Current |